
Sign up to save your podcasts
Or


Heather Turner, CEO at Carmot Therapeutics, speaks with Venrock partner Nimish Shah to discuss her time as CEO. Turner shares how she guided the company through its acquisition by Roche, advice for other CEOs on the verge of an acquisition, her perspective on the GLP-1 market and what excites her about the future of biotech.
By Venrock, a venture capital firm4.8
6262 ratings
Heather Turner, CEO at Carmot Therapeutics, speaks with Venrock partner Nimish Shah to discuss her time as CEO. Turner shares how she guided the company through its acquisition by Roche, advice for other CEOs on the verge of an acquisition, her perspective on the GLP-1 market and what excites her about the future of biotech.

1,285 Listeners

2,706 Listeners

2,462 Listeners

1,096 Listeners

339 Listeners

322 Listeners

389 Listeners

5,562 Listeners

10,038 Listeners

34 Listeners

527 Listeners

21 Listeners

293 Listeners

473 Listeners

1,425 Listeners